NYSE$RMD

ResMed Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

ResMed's second-quarter results reflected continued solid performance with top-line growth and double-digit improvement in operating income and earnings per share.

ResMed Inc. reported a 9% increase in revenue to $800.0 million for the second quarter of fiscal year 2021. GAAP diluted earnings per share were $1.23, and non-GAAP diluted earnings per share were $1.41. The company saw growth in its core markets and adoption of digital health solutions.

  • Revenue increased by 9% year-over-year to $800.0 million.
  • GAAP gross margin was 57.8%, while non-GAAP gross margin expanded to 59.9%.
  • Net operating profit increased by 12%, and non-GAAP operating profit rose by 16%.
  • GAAP diluted earnings per share reached $1.23, and non-GAAP diluted earnings per share were $1.41.

Headline financials

Total Revenue

$800M

Previous: $736M+8.7%
EPS (adj)

$1.41

Previous: $1.21+16.5%
Research and development expenses

$54.9M

No prior period
Capital Expenditures

-$48.4M

Previous: -$47.8M-1.4%
Free Cash Flow

$131M

Previous: $113M+16.2%
Net Income

$180M

Previous: $161M+11.8%
Operating Income

$222M

Previous: $198M+12.1%
Gross Profit

$462M

Previous: $427M+8.3%
Cash & Equivalents

$256M

Previous: $204M+25.4%
Total Assets

$4.57B

Previous: $4.35B+5.0%
Stock-Based Comp

$15.4M

Previous: $14.1M+9.4%

Revenue & EPS history

ResMed · Revenue · Quarterly

$800M

Q2 2021+8.7%vs Q2 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

ResMed · $800M total across 3 segments · Q2 2021

  • Total Devices
    $393M+7.4%
  • Total Masks and other
    $315M+11.1%
  • Residential Care Software
    $91.8M

Forward guidance

No specific forward guidance was provided in the release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+0.1%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.2%

Avg return

30 days after

49%

33 / 67 earnings

Positive

+18.7%

Q3 2024

Best reaction

-19.3%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-2.9%-2.0%-10.8%
Q2 2026-1.5%+2.1%-0.5%
Q1 2026-1.5%-2.8%+1.4%
Q3 2025+10.1%+10.9%+13.2%
Q2 2025-8.3%-5.8%-9.4%
Q1 2025+7.9%+2.9%+2.7%
Q4 2024+4.9%+2.6%+14.9%
Q3 2024+18.7%+16.4%+16.0%
Q2 2024+6.5%+9.3%+5.2%
Q1 2024-4.2%+0.5%+9.5%
Q4 2023-19.3%-19.3%-28.3%
Q3 2023+7.6%+5.4%-3.8%
Q2 2023-2.8%-1.2%-8.5%
Q1 2023-6.5%-5.6%-1.7%
Q4 2022-1.5%-3.1%-3.1%
Q3 2022-6.9%-8.5%-3.0%
Q2 2022-6.5%+0.5%+6.2%
Q1 2022-1.9%-2.1%-6.3%
Q4 2021+0.5%+0.7%+8.3%
Q3 2021-10.6%-8.6%-2.0%
Q2 2021-5.8%-3.5%-9.9%
Q1 2021+6.2%+12.1%+16.0%
Q4 2020-13.4%-13.6%-14.4%
Q3 2020+1.8%+2.0%+2.9%
Q2 2020-4.1%+0.6%-4.1%
Q1 2020+13.8%+15.7%+14.6%
Q4 2019+1.1%+3.8%+5.4%
Q3 2019+7.9%+7.6%+9.3%
Q2 2019-19.3%-21.5%-13.6%
Q1 2019+6.2%+7.3%+5.7%
Q4 2018-2.1%+0.7%+4.1%
Q3 2018-2.1%-1.4%+6.9%
Q2 2018+13.2%+15.9%+5.1%
Q1 2018+7.7%+7.4%+8.6%
Q4 2017-6.0%-2.6%+0.6%
Q3 2017-5.2%-2.7%-2.3%
Q2 2017+9.5%+7.1%+13.7%
Q1 2017-5.0%-5.3%-8.7%
Q4 2016+5.8%+6.5%+6.0%
Q3 2016-7.4%
Q2 2016+7.1%
Q1 2016+0.1%
Q4 2015+3.6%
Q3 2015-10.3%
Q2 2015+8.6%
Q1 2015+9.5%
Q4 2014-4.1%
Q3 2014-0.4%
Q2 2014-5.7%
Q1 2014-13.2%
Q4 2013+0.5%
Q3 2013+0.9%
Q2 2013+7.0%
Q1 2013-4.7%
Q4 2012+12.8%
Q3 2012+7.6%
Q2 2012+9.7%
Q1 2012-12.0%
Q4 2009-5.4%
Q4 2011-5.4%
Q3 2011-0.9%
Q3 2010-0.9%
Q2 2010+2.2%
Q2 2011+2.2%
Q1 2010+3.6%
Q1 2011+3.6%
Q4 2010+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro